Topic Cardiac resynchronization therapy
To replace or to abandon and implant a new lead? Conservative approach creates new challenges (and risks) for the patients in future. Should we still wait for class 1 indications ? Case report and discussion of the problem.
Paweł Stefańczyk, Wojciech Borzęcki, Łukasz Tułecki, Konrad Tomków, Dorota Nowosielecka, Andrzej Kleinrok, Andrzej Kutarski
Heart Beat 2019;4:16–19
A rare complication: Right Contralateral Hemopneumothorax After Pacemaker Implantation
Heart Beat 2019;4:8–10
Left bundle branch block and peripartum cardiomyopathy – review on recent evidence
Heart Beat 2018;3:117–119
Implantation of cardiac resynchronization therapy through persistent left superior vena cava.
Heart Beat 2018;3:77–79
The latest research in telecardiology presented on ESC Congress 2018
Heart Beat 2018;3:69–71
No benefits from exercise training and worse outcomes in heart failure patients with atrial fibrillation and cardiovascular implantable electronic devices.
Rafał Dąbrowski, Edyta Smolis-Bąk, Ilona Kowalik, Marcin Dobrowolski, Justyna Mączynska, Laura Załucka, Hanna Rymuza, Barbara Jędrzejczyk, Maciej Sterliński, Mariusz Pytkowski, Hanna Szwed
Heart Beat 2018;3:61–68
Sacubitril/valsartan and the risk of sudden cardiac death
Heart Beat 2018;3:59–60
What is the conclusion from the DECODE CRT-D study?
Heart Beat 2018;3:54–55
Left Ventricular Pacing via Coronary Sinus in a Patient With a Mechanical Tricuspid Valve.
Jakub Zawadzki, Łukasz Januszkiewicz, Andrzej Cacko, Marcin Michalak, Grzegorz Opolski, Marcin Grabowski
Heart Beat 2017;2:36–37
Relation between left ventricular wall dimensions in cardiac resynchronization therapy candidates and echocardiographic and clinical outcome.
Heart Beat 2017;2:27–32
